Hui Wang, Weijuan Chen

Shouguang Municipal People's Hospital

Abstract：

Objective To investigate the clinical value of bronchial artery embolisation (BAE) in the endoscopic interventional management of central airway malignancies. Method A total of 86 patients with central airway malignancies admitted to our hospital between January 2021 and January 2024 were enrolled. They were randomly assigned using a random number table to either the experimental group (n=43) or the control group (n=43). Patients in the control group underwent direct endoscopic intervention, while those in the experimental group received bronchial artery embolisation 24–48 hours prior to endoscopic intervention. Intraoperative blood loss, procedure duration, tumour resection rate, complication incidence, and postoperative quality of life were compared between groups. Result Intraoperative blood loss was significantly lower in the experimental group than the control group (P < 0.001). The experimental group exhibited markedly shorter operative times compared to the control group (P < 0.001). The experimental group demonstrated a higher rate of complete tumour resection than the control group (P < 0.05). The incidence of postoperative complications was lower in the experimental group than in the control group (P < 0.05). Quality of life scores were significantly superior in the experimental group patients (P < 0.05). Conclusion Bronchial artery embolisation demonstrates significant clinical value in the endoscopic interventional management of central airway malignancies. It effectively reduces intraoperative haemorrhage, enhances tumour resection rates, lowers complication incidence, and improves patient quality of life, warranting wider clinical adoption.

Key Words：

bronchial artery embolisation; central airway malignancy; endoscopic interventional therapy